BioCentury
ARTICLE | Company News

Beckman Coulter sales and marketing update

November 25, 2002 8:00 AM UTC

BEC launched its Class II iTAg tetramer reagents for autoimmune disease research. BEC said the tetramers detect and quantify CD4+ antigen-specific T cells involved in diseases like type I diabetes, rh...